Skip to search formSkip to main contentSkip to account menu

MK-185

Known as: MK 185, MK185 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Halofenate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.
1975
1975
Halofenate (MK-185) 投与による血中脂質の変動
1974
1974
Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes.
1973
1973
Thyroid hormone binding in dog plasma.
Polyacrylamide gel electrophoresis studies at pH 7.4 of 125 I-T4 distribution in dog plasma have denned 3 binding proteins: 2… 
1973
1973
The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia.
1972
1972
Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.
MK-185 (halofenate) is a hypo-lipidemic agent which has been shown in short-term clinical trials in hyperlipidemic patients to… 
1972
1972
Clinical evaluation of MK-185: A new hypolipidemic drug
A double-blind crossover study in 11 patients suggests that MK-185 may be a useful drug in lowering plasma triglyceride levels… 
1971
1971
Hypolipidemic, uricosuric, and thyroxine‐displacing effects of MK‐185 (halofenate)
MK‐185, an ester structurally related to clofibrate, was given to hypertriglyceridemic patients for 6 week periods in a… 
1971
1971
The effects of MK‐185 on thyroid function
MK‐185, (2‐acetoamidoethyl [4‐chlorophenyl] [3‐trifluoromethyl phenoxy] acetate) produced a significant reduction in serum… 
1970
1970
The effect of MK‐185 on some aspects of uric acid metabolism
Following oral administration of MK‐185 to 10 patients with types III, IV, or V hyperlipoproteinemia at doses of 10, 15, and 20… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)